Hepatocyte growth factor is associated with progression of atherosclerosis: The Multi-Ethnic Study of Atherosclerosis

Elizabeth J Bell1, Paul A Decker2, Michael Y Tsai3

  • 1Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.

Atherosclerosis
|April 3, 2018
PubMed

Insights

Higher levels of hepatocyte growth factor (HGF) are linked to increased atherosclerosis progression, including coronary artery calcium and carotid plaque. This finding highlights HGF as a potential biomarker for cardiovascular disease risk.

Area of Science:

  • Cardiovascular Science
  • Biomarker Discovery
  • Medical Research

Background:

  • Hepatocyte growth factor (HGF) has been previously linked to cardiovascular diseases like stroke and atherosclerosis.
  • The study investigates the association between circulating HGF levels and the progression of atherosclerosis measures.

Purpose of the Study:

  • To determine if higher circulating HGF levels are associated with greater progression of coronary artery calcium (CAC) and carotid plaque.
  • To explore HGF as a potential clinical biomarker for cardiovascular disease.

Main Methods:

  • Utilized data from the Multi-Ethnic Study of Atherosclerosis (MESA) cohort.
  • Measured HGF at baseline and followed participants for up to 12 years for atherosclerosis progression.
  • Employed mixed-effects models and relative risk regression, adjusting for confounding variables.

Main Results:

  • Each standard deviation increase in HGF was associated with a 2.9 Agatston units/year greater CAC progression (p < 0.0001).
  • The association between HGF and CAC progression varied significantly by race/ethnicity (p=0.003).
  • Each standard deviation increase in HGF was linked to a 4% higher risk of new or additional carotid plaque (p=0.005).

Conclusions:

  • Elevated circulating HGF levels are significantly associated with accelerated atherosclerosis progression.
  • HGF shows promise as a valuable clinical biomarker for identifying individuals at higher risk of cardiovascular disease.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
442
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.1K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
568
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
466
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.0K
Factors Influencing Microbial Growth: pH01:29

Factors Influencing Microbial Growth: pH

Microorganisms are classified as acidophiles, neutrophiles, or alkaliphiles based on their pH growth preferences, reflecting their adaptations to specific environments. Maintaining a stable intracellular pH is critical for macromolecular stability and enzymatic activity, which can be challenged by external pH variations.Neutrophiles, such as Escherichia coli, grow optimally between pH 5.5 and 8.0. These microorganisms inhabit neutral or slightly acidic environments and employ mechanisms like...
1.3K